# How Should Hospitals Design Medical Device Segmentation Architecture in 2026?

hygiea.tech · September 24, 2026

> What Medical Device Segmentation Architecture Actually Means Medical device segmentation is the design of network, identity, monitoring, and policy...

## What Medical Device Segmentation Architecture Actually Means

Medical device segmentation is the design of network, identity, monitoring, and policy controls that limit where medical devices, clinical applications, and supporting services can communicate. In a hospital, that may mean keeping an infusion pump from initiating unrestricted connections to other clinical devices, separating diagnostic imaging systems from internet access, or preventing a compromised environmental sensor from reaching an electronic health record. It is not a single product and should not be treated as a new VLAN diagram. The useful architecture combines asset discovery, reliable device identity, segmented network zones, application-level enforcement, and rapid containment without disrupting care delivery. For healthcare operators, the objective is to reduce the blast radius of a failure while preserving the availability and response times expected in clinical environments.

**Also worth reading:** [How Much Does Medical Image Segmentation Cost in 2026, and What Should Healthcare Buyers Budget?](https://hygiea.tech/knowledge/how_much_does_medical_image_segmentation_cost_in_2026_and_what_should_healthcare_buyers_budget.php) · [How Does Zero Trust Medical Device Onboarding Protect Modern Hospital Networks?](https://hygiea.tech/knowledge/how_does_zero_trust_medical_device_onboarding_protect_modern_hospital_networks.php) · [What are medical device network visibility tools and how do health systems manage thousands of connected assets?](https://hygiea.tech/knowledge/what_are_medical_device_network_visibility_tools_and_how_do_health_systems_manage_thousands_of_connected_assets.php)

The phrase can also refer to medical image segmentation, where software identifies anatomical structures in CT, MRI, or ultrasound images. Models such as V-UNet and lightweight SwiM-UNet address image processing rather than hospital network security, and the latter focuses on efficient on-device computation. Those workloads matter when imaging workstations or portable scanners need local processing, but they should not be confused with network segmentation. A hygiene and safety-operations platform may ingest readings from both categories, yet a compromised sensor, a clinical workstation, and a segmentation model have different risks and require different controls. The direct answer for hospitals is therefore to build a risk-based, identity-aware segmentation architecture for connected medical devices, with special handling for legacy equipment and life-safety workflows.

## A Practical Reference Architecture for Connected Devices

A workable design usually has six functional layers: discovery, inventory, identity, segmentation, enforcement, and response. Discovery identifies devices through passive network telemetry, DHCP records, switch port data, address observations, and approved management integrations; active scanning should be limited because some clinical devices can be sensitive to unexpected traffic. Inventory then records ownership, manufacturer, model, serial number, firmware version, clinical location, vendor, data class, and expected communications for every device. Identity assigns a confidence-rated identity based on factors such as 802.1X certificates, MAC evidence, switch port, service behavior, and management enrollment. The supplied research on OT zero trust indicates that operators increasingly evaluate segmentation and resilience as operational capabilities rather than relying only on user identity.

Enforcement can use physical or virtual network zones, stateful firewalls, identity-based microsegmentation, or a combination of these controls. Policy should begin with the normal communication required for treatment, diagnostics, monitoring, maintenance, and clinical records, then deny unneeded east-west and outbound connections. A typical architecture places infusion systems, diagnostic equipment, imaging and PACS systems, environmental sensors, building systems, administrative workstations, and guest traffic in distinct policy groups even if some groups share VLANs. Medical images deserve separate treatment from ordinary IoT because DICOM transfers can involve large data volumes and hundreds of devices, so segmentation around the PACS and archive may be more effective than a rule for every workstation. For hygiene programs, temperature probes, soap dispensers, water sensors, and cleaning-equipment gateways should be placed according to operational risk and data sensitivity rather than grouped simply because they are wireless accessories.

Response completes the architecture by feeding identity, network, and device-health events into a SIEM or safety-operations platform. When a pump or sensor behaves unlike its baseline, the platform can disable internet access, quarantine the device at the switch, revoke a certificate, or restrict the device to a maintenance enclave. Automated actions must be tested against clinical tolerances: isolating a monitoring device may be appropriate, while taking an infusion pump offline without a safe alternative may create harm. Every automated rule needs an owner, an audit trail, an expiration date where temporary, and a tested recovery procedure. This makes segmentation part of patient safety and operational resilience rather than only a security project.

## How Device Identification and Traffic Policy Should Work

Device discovery should be continuous because hospitals add pumps, sensors, workstations, imaging systems, and vendor appliances faster than annual inventories are updated. A useful baseline is 100% documentation for devices that directly support patient care or safety operations, with coverage above 98% for the broader medical IoT estate. Passive methods are generally safer for clinical networks, while active sweeps can be run only on approved segments at controlled times. Each discovered device should have a confidence score that distinguishes verified management enrollment from a guessed identity based on MAC address and network location. A physical connection to a clinical switch port is evidence, but it is not proof that the device is genuine.

The policy engine should translate each device class into explicit communication rules. A hand-hygiene monitor may need inbound connections from a management service and outbound connections to a specific cloud endpoint, but it should not initiate connections to clinical workstations. A diagnostic workstation may need PACS access, identity services, time synchronization, and software updates, while access to peer workstations should be denied by default. A legacy pump without modern identity support may require a dedicated gateway that presents one controlled address to the rest of the network. The design target is least privilege at the actual application flow level, including source, destination, service, direction, and clinical context, not merely a rule that blocks port 443.

| Feature | Traditional VLAN zones | Identity-aware microsegmentation |
| --- | --- | --- |
| Enforcement unit | Broadcast domain and subnet | Logical policy group or workload |
| Device identity | Usually port, IP, or switch location | Certificate, management enrollment, behavior, and context |
| Legacy support | Often straightforward through gateways | Requires protocol-aware gateways or temporary exceptions |
| Main strength | Simple and inexpensive | Smaller blast radius and better device-level policy |
| Main weakness | Flat subnets permit lateral movement | Cost, integration effort, and policy complexity |
| Best deployment role | Coarse separation of major trust zones | High-risk clinical services, cross-zone flows, and sensitive assets |

Organizations should not choose one column as a universal winner. VLANs remain practical for containing broadcasts and separating broad device classes, while identity-aware controls are more useful where flat clinical networks create unacceptable lateral movement. Many mature programs use both, with the firewall or distributed enforcement point converting an identity-based policy into the appropriate network action. Success should be measured by the number of unauthorized paths eliminated, the time to contain a device, and the percentage of critical devices with a verified owner, rather than by the number of segments created.

## Why Zero Trust Matters for Medical Device Networks

Traditional perimeter security assumes that devices inside the hospital network are more trustworthy than those outside it. That assumption is weak when vendors connect remotely, clinicians use personal devices, building systems exchange operational data, and legacy medical equipment remains in service for years. Zero trust replaces location-based trust with evidence evaluated at access time, including identity, device health, service behavior, location, and management state. NIST SP 800-207 describes zero trust as an approach based on resource access decisions rather than implicit trust based on network position. For medical devices, the practical interpretation is that a device should receive only the data and services required for its current function.

Identity must be treated as a continuum when hardware is old, software cannot be replaced quickly, or manufacturers restrict modification. A certificate-backed infusion pump can receive stronger policy than an unidentified device on the same VLAN, but strong identity on a vulnerable operating system is not equivalent to good security. Patching, hardening, vendor support status, and compensating controls such as gateways must remain visible in the asset record. Research cited on medical microsegmentation notes that legacy architecture and awareness gaps can slow adoption, which supports a phased design rather than a claim that every device will support modern controls equally. Remote vendor sessions should use time-limited, recorded access through a broker, not permanent network routes into the clinical environment.

Compliance requirements reinforce this approach without prescribing one segmentation product. In the United States, the HIPAA Security Rule requires risk-based protections, while FDA cybersecurity guidance for premarket submissions addresses secure design, threat modeling, software bills of materials, and update processes. In Europe, the Cyber Resilience Act entered into force on 10 December 2024, with reporting obligations beginning on 11 September 2026 and its main obligations applying from 11 December 2027. Those dates are important for procurement because device connectivity, vulnerability reporting, and support duration affect segmentation design. Segmentation supports compliance evidence, but a successful project does not by itself prove that a device is safe, patched, or clinically reliable.

## How to Implement Segmentation Without Disrupting Care

Begin with a 6- to 12-week discovery and risk exercise covering clinical floors, imaging, laboratories, biomedical engineering, facilities, and remote-access infrastructure. Assign a clinical owner to each device class so network engineers are not left to infer operational importance from asset names. Map the communications required for normal treatment, emergency operation, vendor maintenance, infection-control workflows, and centralized monitoring. Quantify where the same device identity is trusted across zones, where VLANs permit broad peer access, and where temporary firewall rules have accumulated. The output should be a prioritized segmentation plan, not an inventory that never reaches production.

Next, pilot in a bounded environment with representative equipment and manageable consequences, such as environmental sensors or a non-emergency imaging workflow. Configure monitoring before blocking, compare observed behavior with documented requirements, and resolve unknown flows rather than immediately treating them as malicious. Set measurable service limits for the pilot, including packet loss, application latency, device availability, and recovery time; for example, a remote monitoring path could target less than 10 milliseconds of added gateway latency, but the real threshold must come from the application owner. A useful operational target is isolation of a compromised non-life-critical device within 15 minutes, while higher-risk clinical devices may require a different containment plan. Run clinical simulations during maintenance windows and include downtime procedures in the acceptance test.

Roll out by device class and enforce a default-deny posture for east-west traffic only after required flows are verified. Use staged rules, alerts, and time-limited exceptions so an incorrect assumption does not shut down medication delivery or diagnostic services. Integrate device states with shift and context information so a sensor under maintenance is treated differently from an infusion pump in active use. Record approvals, policy versions, identities, and enforcement outcomes in the system of record, then review them during access reviews and incident exercises. A realistic hospital program often takes 6-18 months, although a clinic may complete a smaller deployment faster because it has fewer device classes and network zones.

## Comparing Build, Buy, and Managed Options

Healthcare organizations can construct controls around existing switches, firewalls, and network access controllers, buy an identity-aware segmentation platform, or engage a managed service provider. Building directly offers the greatest control over policies and may fit organizations with strong networking, security, clinical engineering, and compliance teams. It can also leave the hospital responsible for agent compatibility, hardware refresh, policy operations, and continuous tuning. Buying a platform can shorten deployment because some vendors provide passive discovery, logical policy groups, and integrations with existing firewalls, but licenses may not include switches, firewall capacity, or the work required to remediate unsafe device configurations. Managed services can provide 24/7 monitoring and contain staffing gaps, yet hospitals must ensure the provider understands clinical availability and has a contractual process for emergency changes.

| Decision factor | Internal build | Segmentation platform purchase | Managed segmentation service |
| --- | --- | --- | --- |
| Control over design | Highest | High within vendor limits | Depends on contract and client approvals |
| Typical staffing need | Network, security, clinical engineering, compliance | Network and security team plus vendor support | Smaller internal team with on-call provider support |
| Upfront complexity | Hardware and integration work | Licensing, adapters, and deployment work | Less hardware procurement, but service fees continue |
| Best fit | Mature enterprise environment | Mixed hospital infrastructure needing device-level policy | Smaller organizations or limited security operations coverage |
| Principal risk | Projects stall after policy design | Tool remains underused or produces excessive alerts | Provider may lack deep clinical-device knowledge |

A fair comparison should include three-year total cost, not only subscription price. Buyers should ask whether legacy protocols are supported, whether the platform identifies devices without agents, how cloud and vendor traffic is handled, and whether policies can be exported for audit evidence. Clinical stakeholders should test whether a failed controller or license expiration can create unsafe isolation. The best option is the one that the hospital can operate after the implementation team leaves, with clear ownership of exceptions and quarterly validation of device behavior.

## Common Mistakes That Can Cause Clinical or Security Failures

The first major mistake is treating every IoT device as a computer that can receive the same controls as a managed laptop. Pumps, monitors, dispensers, imaging systems, and sensors differ in processing capacity, software support, communication patterns, and clinical consequence. A second mistake is creating dozens of VLANs while still allowing broad bidirectional access between them, which increases operational burden without reducing reachable assets. A third is trusting MAC addresses as permanent identity, even though addresses can be copied, reset, or reassigned. Policies based only on IP addresses are also fragile when dynamic addressing changes or a clinician connects a workstation to the wrong port.

Aggressive enforcement without a rollback plan is another frequent failure. Deny-by-default is appropriate as a destination, but it should be applied through tested transitions rather than a single irreversible network change. Teams also tend to ignore maintenance paths, backup systems, biomedical-engineering tools, time synchronization, and emergency procedures until the first outage. A segmentation platform that cannot understand these dependencies can isolate a device from the service it needs to deliver care. Finally, security teams may quarantine a compromised device without preserving volatile evidence, while clinical teams may reconnect it informally to restore the workflow. Response playbooks should define containment, evidence capture, safe substitution, and restoration before incidents occur.

Metrics should reveal whether the design is working without encouraging pointless alerts. Useful measures include verified ownership of life-critical devices, percentage of unknown east-west flows, mean time to revoke credentials, time to isolate a non-life-critical device, and the age of temporary rules. For example, a hospital might require all temporary access rules to expire within 30 days unless an accountable owner renews them, and all critical vendor paths to be reviewed quarterly. These are governance targets rather than universal regulatory thresholds, so leaders should adjust them to risk and staffing. A steady decline in undocumented paths is generally more informative than a sudden increase in segment count.

## Expected Cost, Pricing, and Staffing

Costs vary mainly with device count, network age, identity capability, and whether the program includes new hardware. A small clinic with managed switches, a cloud firewall, and a limited number of connected devices may spend roughly $10,000-$50,000 for an initial assessment, configuration, and basic monitoring. A hospital with several hundred or more devices, multiple sites, legacy equipment, and clinical applications may face $100,000-$500,000 or more for a first deployment. Enterprise programs that replace access-layer hardware, integrate enterprise identity, or use distributed microsegmentation can reach $500,000-$2 million or beyond. These are planning ranges, not vendor quotations, and should be validated through discovery and a proof of concept.

Recurring costs may include software subscriptions, management appliances, firewall capacity, switches with 802.1X support, annual support, staff time, and testing of vendor equipment. A reasonable evaluation should separate one-time capital expenses from three-year operating costs and identify the point at which the program depends on external expertise. Hospitals without a 24/7 security operations function may find managed monitoring economical, but must budget clinical-engineering participation in rule approvals and incident exercises. Cheaper tools can be appropriate for a limited clinic, while underinvesting in discovery and clinical validation often creates expensive remediation later. Procurement language should also require support periods, vulnerability disclosure, patch responsibilities, and evidence that a vendor will not end support for a device still in clinical use.

## When to Act and How to Govern the Program

A hospital should act immediately when connected devices have unknown owners, remote vendor access reaches broad clinical subnets, or a single compromised endpoint could expose diagnostic or medication-delivery systems. Segmentation is also warranted when a health system acquires another provider, centralizes environmental and infection-control monitoring, or adopts a large number of wearable or home-care devices. Aging populations and rising chronic disease burden are expanding the number of devices that transmit clinical or operational data, although market growth figures do not determine a specific security budget. Organizations should review the architecture at least annually and after major acquisitions, network migrations, medical-device replacements, or changes to cloud connectivity.

Governance should sit with a group representing clinical operations, nursing, biomedical engineering, facilities, privacy, compliance, IT security, and network operations. The group should approve device classes, maximum tolerated service interruption, emergency-access rules, and criteria for automatic isolation. Each high-risk device should have a named clinical owner and a technical owner, while temporary rules should carry an expiration date and renewal decision. Independent testing should periodically attempt unauthorized connections from a representative device, verify that the attempt is logged, and confirm that containment can be reversed safely. A quarterly review of access, device health, unsupported software, and unresolved exceptions is a practical minimum, with more frequent reviews for infusion, imaging, and life-support systems.

The defensible long-term position is not maximum isolation, because clinical care depends on controlled communication. It is verified identity, limited reachability, observable behavior, fast containment, and a recovery path tested by the people who operate the device. A successful architecture makes unsafe lateral movement harder without making the hospital less available to patients. That balance should be stated explicitly in procurement documents, measured during pilots, and revisited whenever devices, regulations, or clinical workflows change.

## Quick answers

### Is medical device segmentation the same as medical image segmentation?

No. Network segmentation controls how medical devices communicate; image segmentation identifies structures inside medical images. They can intersect when imaging devices send data, but a V-UNet or SwiM-UNet model does not provide network isolation.

### Can hospitals secure medical devices that do not support modern security agents?

Often, yes. Passive discovery, dedicated gateways, network access control, switch-port restrictions, and monitored protocol proxies can protect devices that cannot run an endpoint agent. The exception should be documented, reviewed, and accompanied by vendor support and vulnerability-management plans.

### Does HIPAA require hospitals to use microsegmentation?

HIPAA does not prescribe one network architecture. It requires a risk-based security program, so segmentation may be an appropriate control for the risks identified in a particular environment. FDA device guidance and European cybersecurity requirements add other design, update, and reporting considerations.

### How long does a hospital device-segmentation program take?

A limited clinic deployment may take several months, while a multi-site hospital program commonly requires 6-18 months. The schedule depends more on device discovery, clinical validation, legacy constraints, and network replacement than on installing a segmentation tool.

### What is a reasonable first step for a hospital with a flat clinical network?

Start with passive discovery, device ownership, and communication mapping for the highest-risk clinical areas. Pilot segmentation on a bounded device class, measure application performance, and expand after required workflows and emergency recovery procedures are proven.

Canonical: https://hygiea.tech/knowledge/how_should_hospitals_design_medical_device_segmentation_architecture_in_2026.php
Markdown: https://hygiea.tech/knowledge/how_should_hospitals_design_medical_device_segmentation_architecture_in_2026.php/index.md